NP Life Sciences Health Industry Group annual return on equity
2020
2021
2022
2023
NP Life Sciences Health Industry Group Return on Equity (ROE) Growth & History (ACAT)
NP Life Sciences Health Industry Group's return on equity was −16.44% for fiscal 2023.
View full NP Life Sciences Health Industry Group company overviewNP Life Sciences Health Industry Group annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −16.44% | +49.16 pp |
| 2022 | 2022-12-31 | −65.60% | +26.89 pp |
| 2021 | 2021-12-31 | −92.49% | −15.11 pp |
| 2020 | 2020-12-31 | −77.38% | — |
NP Life Sciences Health Industry Group quarterly return on equity
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −10.00% | — |
| Q4 2023 | 2023-12-31 | −156.63% | −307.28 pp |
| Q3 2023 | 2023-09-30 | −76.22% | +23.82 pp |
| Q2 2023 | 2023-06-30 | 162.45% | +148.31 pp |
| Q1 2023 | 2023-03-31 | 6.13% | +143.55 pp |
| Q4 2022 | 2022-12-31 | 150.66% | +4.80 pp |
| Q3 2022 | 2022-09-30 | −100.04% | +27.13 pp |
| Q2 2022 | 2022-06-30 | 14.15% | +113.23 pp |
| Q1 2022 | 2022-03-31 | −137.42% | −110.99 pp |
| Q4 2021 | 2021-12-31 | 145.86% | +164.74 pp |
| Q3 2021 | 2021-09-30 | −127.17% | −108.63 pp |
| Q2 2021 | 2021-06-30 | −99.08% | −68.93 pp |
| Q1 2021 | 2021-03-31 | −26.43% | −12.73 pp |
| Q4 2020 | 2020-12-31 | −18.88% | −2.37 pp |
| Q3 2020 | 2020-09-30 | −18.53% | +6.32 pp |
| Q2 2020 | 2020-06-30 | −30.15% | — |
| Q1 2020 | 2020-03-31 | −13.70% | — |
| Q4 2019 | 2019-12-31 | −16.52% | — |
| Q3 2019 | 2019-09-30 | −24.85% | — |
NP Life Sciences Health Industry Group return on equity trends
Between the periods ended 2020-12-31 and 2023-12-31, NP Life Sciences Health Industry Group's return on equity increased from −77.38% to −16.44%, a change of +60.93 percentage points. The latest reported quarter, Q1 2025, shows −10.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NP Life Sciences Health Industry Group source filings ↗